Abstract
Introduction: Acute and long-term adverse effects of heavy cannabis use (HCU) on neurocognitive function have been suggested, as much as regional changes of brain volume. However, little is known about the relationship between impaired cognition and brain structure in individuals with HCU. Objective: Here, we investigated associations between cognition and cortical thickness (CT) in males with HCU and male controls. Methods: Twenty-six individuals with HCU and 20 controls were examined using a comprehensive neuropsychological test battery and high-resolution structural MRI at 3T. CT was calculated using the Computational Anatomy Toolbox (CAT12). Results: Individuals with HCU differed from controls with respect to verbal learning performance and verbal working memory only. Individuals with HCU showed reduced CT in medial temporal, orbitofrontal, and cingulate regions, as well as in areas of the middle temporal and fusiform cortex (peak voxel family-wise error-corrected p < 0.001, followed by empirically determined correction for spatial extent) compared to HC. Verbal learning performance was associated with right entorhinal and left orbitofrontal CT reductions. Entorhinal CT was also significantly associated with amount and frequency of current weekly cannabis use. Conclusions: The data support the notion of domain-specific cognitive impairment in individuals with HCU and provide a neuromechanistic understanding of such deficits, particularly with respect to abnormal CT in brain areas associated with long-term memory processing.
References
1.
Addiction EMCfdad
. European drug report
. 2016
.2.
Broyd
SJ
, van Hell
HH
, Beale
C
, Yücel
M
, Solowij
N
. Acute and chronic effects of cannabinoids on human cognition-a systematic review
. Biol Psychiatry
. 2016
;79
(7
):557
–67
. 3.
Pope
HG
Jr, Gruber
AJ
, Hudson
JI
, Huestis
MA
, Yurgelun-Todd
D
. Neuropsychological performance in long-term cannabis users
. Arch Gen Psychiatry
. 2001
;58
(10
):909
–15
. 4.
Epstein
KA
, Kumra
S
. Altered cortical maturation in adolescent cannabis users with and without schizophrenia
. Schizophr Res
. 2015
;162
(1–3
):143
–52
. 5.
Rais
M
, van Haren
NE
, Cahn
W
, Schnack
HG
, Lepage
C
, Collins
L
, et al. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia
. Eur Neuropsychopharmacol
. 2010
;20
(12
):855
–65
. 6.
Jacobus
J
, Squeglia
LM
, Meruelo
AD
, Castro
N
, Brumback
T
, Giedd
JN
, et al. Cortical thickness in adolescent marijuana and alcohol users: a three-year prospective study from adolescence to young adulthood
. Dev Cogn Neurosci
. 2015
;16
:101
–9
. 7.
Filbey
FM
, McQueeny
T
, DeWitt
SJ
, Mishra
V
. Preliminary findings demonstrating latent effects of early adolescent marijuana use onset on cortical architecture
. Dev Cogn Neurosci
. 2015
;16
:16
–22
. 8.
Levar
N
, Francis
AN
, Smith
MJ
, Ho
WC
, Gilman
JM
. Verbal memory performance and reduced cortical thickness of brain regions along the uncinate fasciculus in young adult cannabis users
. Cannabis Cannabinoid Res
. 2018
;3
(1
):56
–65
. 9.
Yücel
M
, Lorenzetti
V
, Suo
C
, Zalesky
A
, Fornito
A
, Takagi
MJ
, et al. Hippocampal harms, protection and recovery following regular cannabis use
. Transl Psychiatry
. 2016
;6
:e710
. 10.
Medina
KL
, McQueeny
T
, Nagel
BJ
, Hanson
KL
, Yang
TT
, Tapert
SF
. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects
. Addict Biol
. 2009
;14
(4
):457
–68
. 11.
Jager
G
, Van Hell
HH
, De Win
MM
, Kahn
RS
, Van Den Brink
W
, Van Ree
JM
, et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task
. Eur Neuropsychopharmacol
. 2007
;17
(4
):289
–97
. 12.
Lorenzetti
V
, Lubman
DI
, Whittle
S
, Solowij
N
, Yücel
M
. Structural MRI findings in long-term cannabis users: what do we know?
Subst Use Misuse
. 2010
;45
(11
):1787
–808
. 13.
Anderson
BM
, Rizzo
M
, Block
RI
, Pearlson
GD
, O’Leary
DS
. Sex, drugs, and cognition: effects of marijuana
. J Psychoactive Drugs
. 2010
;42
(4
):413
–24
. 14.
Pushkin
AN
, Eugene
AJ
, Lallai
V
, Torres-Mendoza
A
, Fowler
JP
, Chen
E
, et al. Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood
. PLoS One
. 2019
;14
(1
):e0211346
. 15.
Kirschmann
EK
, McCalley
DM
, Edwards
CM
, Torregrossa
MM
. Consequences of adolescent exposure to the cannabinoid receptor agonist WIN55,212-2 on working memory in female rats
. Front Behav Neurosci
. 2017
;11
:137
. 16.
Lippard
ETC
, Mazure
CM
, Johnston
JA
, Spencer
L
, Weathers
J
, Pittman
B
, et al. Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents
. J Neurosci Res
. 2017
;95
(1–2
):777
–91
. 17.
Hunt
GE
, Malhi
GS
, Cleary
M
, Lai
HM
, Sitharthan
T
. Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990–2015: systematic review and meta-analysis
. J Affect Disord
. 2016
;206
:331
–49
. 18.
Ramlakhan
JU
, Zomorrodi
R
, Downar
J
, Blumberger
DM
, Daskalakis
ZJ
, George
TP
, et al. Using mismatch negativity to investigate the pathophysiology of substance use disorders and comorbid psychosis
. Clin EEG Neurosci
. 2018
;49
(4
):226
–37
. 19.
Destoop
M
, Morrens
M
, Coppens
V
, Dom
G
. Addiction, anhedonia, and comorbid mood disorder. a narrative review
. Front Psychiatry
. 2019
;10
:311
. 20.
Solowij
N
, Battisti
R
. The chronic effects of cannabis on memory in humans: a review
. Curr Drug Abuse Rev
. 2008
;1
(1
):81
–98
. 21.
Solowij
N
, Stephens
RS
, Roffman
RA
, Babor
T
, Kadden
R
, Miller
M
, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment
. JAMA
. 2002
;287
(9
):1123
–31
. 22.
Cohen
K
, Kapitány-Fövény
M
, Mama
Y
, Arieli
M
, Rosca
P
, Demetrovics
Z
, et al. The effects of synthetic cannabinoids on executive function
. Psychopharmacology
. 2018
;234
(7
):1121
–34
. 23.
Crean
RD
, Crane
NA
, Mason
BJ
. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions
. J Addict Med
. 2011
;5
(1
):1
–8
. 24.
Mashhoon
Y
, Sava
S
, Sneider
JT
, Nickerson
LD
, Silveri
MM
. Cortical thinness and volume differences associated with marijuana abuse in emerging adults
. Drug Alcohol Depend
. 2015
;155
:275
–83
. 25.
El Marroun
H
, Tiemeier
H
, Franken
IH
, Jaddoe
VW
, van der Lugt
A
, Verhulst
FC
, et al. Prenatal cannabis and tobacco exposure in relation to brain morphology: a prospective neuroimaging study in young children
. Biol Psychiatry
. 2016
;79
(12
):971
–9
. 26.
Cousijn
J
, Wiers
RW
, Ridderinkhof
KR
, van den Brink
W
, Veltman
DJ
, Goudriaan
AE
. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls
. NeuroImage
. 2012
;59
(4
):3845
–51
. 27.
Hester
R
, Nestor
L
, Garavan
H
. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users
. Neuropsychopharmacology
. 2009
;34
(11
):2450
–8
. 28.
Nestor
L
, Roberts
G
, Garavan
H
, Hester
R
. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users
. NeuroImage
. 2008
;40
(3
):1328
–39
. 29.
Rösler
M
, Retz
W
, Retz-Junginger
P
, Thome
J
, Supprian
T
, Nissen
T
, et al. Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter
. Der Nervenarzt
. 2005
;76
(1
):129
–30
.30.
Hautzinger
M
, Keller
F
, Kühner
C
. “BDI II” Beck depressions-inventar (2nd Revision)
. Frankfurt am Main
: Harcourt Test Services
; 2006
.31.
Hamilton
M
. A rating scale for depression
. J Neurol Neurosurg Psychiatry
. 1960
;23
(1
):56
–62
. 32.
Reinert
DF
, Allen
JP
. The alcohol use disorders identification test (AUDIT): a review of recent research
. Alcohol Clin Exp Res
. 2002
;26
(2
):272
–9
. 33.
Fagerström
K-O
, Schneider
NG
. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire
. J Behav Med
. 1989
;12
(2
):159
–82
. 34.
Adamson
SJ
, Sellman
JD
. A prototype screening instrument for cannabis use disorder: the cannabis use disorders identification test (CUDIT) in an alcohol-dependent clinical sample
. Drug Alcohol Rev
. 2003
;22
(3
):309
–15
. 35.
Adamson
SJ
, Kay-Lambkin
FJ
, Baker
AL
, Lewin
TJ
, Thornton
L
, Kelly
BJ
, et al. An improved brief measure of cannabis misuse: the cannabis use disorders identification test-revised (CUDIT-R)
. Drug Alcohol Depend
. 2010
;110
(1–2
):137
–43
. 36.
Ashtari
M
, Cervellione
K
, Cottone
J
, Ardekani
BA
, Sevy
S
, Kumra
S
. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use
. J Psychiatr Res
. 2009
;43
(3
):189
–204
. 37.
Becker
MP
, Collins
PF
, Lim
KO
, Muetzel
RL
, Luciana
M
. Longitudinal changes in white matter microstructure after heavy cannabis use
. Dev Cogn Neurosci
. 2015
;16
:23
–35
. 38.
Shollenbarger
SG
, Price
J
, Wieser
J
, Lisdahl
K
. Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults
. Neuroimage Clin
. 2015
;8
:117
–25
. 39.
Aschenbrenner
S
, Kaiser
S
, Pfüller
U
, Roesch-Ely
D
, Weisbrod
M
. Testset COGBAT
. Mödling
: Schuhfried
; 2012
.40.
Culbertson
WC
, Zillmer
EA
. The tower of London manual
. Multi-Health Systems, Inc.
; 1998
.41.
Dahnke
R
, Yotter
RA
, Gaser
C
. Cortical thickness and central surface estimation
. NeuroImage
. 2013
;65
:336
–48
. 42.
Desikan
RS
, Ségonne
F
, Fischl
B
, Quinn
BT
, Dickerson
BC
, Blacker
D
, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
. NeuroImage
. 2006
;31
(3
):968
–80
. 43.
Mörstedt
B
, Corbisiero
S
, Stieglitz
R-D
. Normierung der adult ADHD self-report-scale-V1.1 und der ADHS Selbstbeurteilungsskala an einer repräsentativen deutschsprachigen Stichprobe
. Diagnostica
. 2016
;62
(4
):199
–211
. 44.
Crane
NA
, Schuster
RM
, Fusar-Poli
P
, Gonzalez
R
. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences
. Neuropsychol Rev
. 2013
;23
(2
):117
–37
. 45.
Hanson
KL
, Winward
JL
, Schweinsburg
AD
, Medina
KL
, Brown
SA
, Tapert
SF
. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence
. Addict Behav
. 2010
;35
(11
):970
–6
. 46.
Solowij
N
, Jones
KA
, Rozman
ME
, Davis
SM
, Ciarrochi
J
, Heaven
PC
, et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users
. Psychopharmacology
. 2011
;216
(1
):131
–44
. 47.
Thames
AD
, Arbid
N
, Sayegh
P
. Cannabis use and neurocognitive functioning in a non-clinical sample of users
. Addict Behav
. 2014
;39
(5
):994
–9
. 48.
Shallice
T
, Fletcher
P
, Frith
CD
, Grasby
P
, Frackowiak
RS
, Dolan
RJ
. Brain regions associated with acquisition and retrieval of verbal episodic memory
. Nature
. 1994
;368
(6472
):633
–5
. 49.
Egerton
A
, Allison
C
, Brett
RR
, Pratt
JA
. Cannabinoids and prefrontal cortical function: insights from preclinical studies
. Neurosci Biobehav Rev
. 2006
;30
(5
):680
–95
. 50.
Glass
M
, Dragunow
M
, Faull
RL
. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
. Neuroscience
. 1997
;77
(2
):299
–318
. 51.
Lorenzetti
V
, Chye
Y
, Silva
P
, Solowij
N
, Roberts
CA
. Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
. Eur Arch Psychiatry Clin Neurosci
. 2019
;269
(1
):59
–71
. 52.
Ashtari
M
, Avants
B
, Cyckowski
L
, Cervellione
KL
, Roofeh
D
, Cook
P
, et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use
. J Psychiatr Res
. 2011
;45
(8
):1055
–66
. 53.
Çolak
Ç
, Çelik
ZÇ
, Zorlu
N
, Kitiı
Ö
, Yüncü
Z
. Cortical thickness and subcortical volumes in adolescent synthetic cannabinoid users with or without ADHD: a preliminary study
. Noro Psikiyatr Ars
. 2019
;56
(3
):167
–72
.54.
Frodl
T
, Skokauskas
N
. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects
. Acta Psychiatr Scand
. 2012
;125
(2
):114
–26
. 55.
Saletin
JM
, Jackvony
S
, Rodriguez
KA
, Dickstein
DP
. A coordinate-based meta-analysis comparing brain activation between attention deficit hyperactivity disorder and total sleep deprivation
. Sleep
. 2019
;42
(3
):zsy251
. 56.
Hoogman
M
, Muetzel
R
, Guimaraes
JP
, Shumskaya
E
, Mennes
M
, Zwiers
MP
, et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples
. Am J Psychiatry
. 2019
;176
(7
):531
–42
.57.
Holmes
AJ
, Hollinshead
MO
, Roffman
JL
, Smoller
JW
, Buckner
RL
. Individual differences in cognitive control circuit anatomy link sensation seeking, impulsivity, and substance use
. J Neurosci
. 2016
;36
(14
):4038
–49
. 58.
Fontes
MA
, Bolla
KI
, Cunha
PJ
, Almeida
PP
, Jungerman
F
, Laranjeira
RR
, et al. Cannabis use before age 15 and subsequent executive functioning
. Br J Psychiatry
. 2011
;198
(6
):442
–7
. 59.
Chye
Y
, Lorenzetti
V
, Suo
C
, Batalla
A
, Cousijn
J
, Goudriaan
AE
, et al. Alteration to hippocampal volume and shape confined to cannabis dependence: a multi-site study
. Addict Biol
. 2019.Jul
;24
(4
):822
–34
.60.
Scott
JC
, Slomiak
ST
, Jones
JD
, Rosen
AFG
, Moore
TM
, Gur
RC
. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis
. JAMA Psychiatry
. 2018
;75
(6
):585
–95
. 61.
Mendiguren
A
, Aostri
E
, Pineda
J
. Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
. Life Sci
. 2018
;192
:115
–27
. 62.
Meruelo
AD
, Castro
N
, Cota
CI
, Tapert
SF
. Cannabis and alcohol use, and the developing brain
. Behav Brain Res
. 2017
;325
(Pt A
):44
–50
. 63.
Blest-Hopley
G
, Giampietro
V
, Bhattacharyya
S
. Residual effects of cannabis use in adolescent and adult brains – a meta-analysis of fMRI studies
. Neurosci Biobehav Rev
. 2018
;88
:26
–41
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
